5:13 PM
 | 
Mar 27, 2013
 |  BC Extra  |  Top Story

FDA approves Biogen Idec's Tecfidera

FDA approved Tecfidera dimethyl fumarate (formerly BG-12) from Biogen Idec Inc. (NASDAQ:BIIB) to treat adults with relapsing forms of multiple sclerosis. Tecfidera's label includes a warning about lymphopenia and recommends health care providers assess a patient's complete blood cell count before and during treatment, but...

Read the full 217 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >